Does CETUXIMAB Cause Therapy partial responder? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Therapy partial responder have been filed in association with CETUXIMAB (ERBITUX). This represents 0.3% of all adverse event reports for CETUXIMAB.
46
Reports of Therapy partial responder with CETUXIMAB
0.3%
of all CETUXIMAB reports
11
Deaths
4
Hospitalizations
How Dangerous Is Therapy partial responder From CETUXIMAB?
Of the 46 reports, 11 (23.9%) resulted in death, 4 (8.7%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which CETUXIMAB Alternatives Have Lower Therapy partial responder Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL